Neurologist-Led Management of Implantable Loop-Recorders After Embolic Stroke of Undetermined Source

Slaven Pikija1, Cornelia Rösler1, Ursula Leitner1

  • 1Department of Neurology, Christian Doppler Medical Center, Paracelsus Medical University, Salzburg, Austria.

Frontiers in Neurology
|February 14, 2022
PubMed

Insights

Neurologists can effectively manage long-term monitoring for atrial fibrillation (AFib) in patients with embolic stroke of undetermined source (ESUS). Earlier loop recorder implantation and specific ECG findings predict AFib detection, supporting neurologist-led care.

Area of Science:

  • Neurology
  • Cardiology
  • Internal Medicine

Background:

  • Embolic stroke of undetermined source (ESUS) accounts for a significant portion of cryptogenic strokes.
  • The role of neurologists in managing long-term monitoring for atrial fibrillation (AFib) in ESUS patients requires further investigation.

Purpose of the Study:

  • To evaluate the feasibility and predictors of AFib detection using implantable loop recorders (ILRs) managed by neurologists in ESUS patients.

Main Methods:

  • A cohort of 131 ESUS patients receiving Reveal LINQ® ILR implantation between 2016-2020 was analyzed.
  • Data collected included demographics, clinical history, ECG, and imaging. AFib detection was defined as >120s duration.
  • Predictors such as PQ interval and supraventricular extrasystoles (SVEs) were assessed.

Main Results:

  • 45 (34%) patients were diagnosed with AFib during a median follow-up of 504 days.
  • Earlier ILR implantation after ESUS was associated with AFib detection (13 vs. 31 days).
  • A prolonged PQ interval and increased SVEs on pre-implantation ECG predicted higher AFib rates.

Conclusions:

  • Neurologist-led management and evaluation of ILRs in ESUS patients is feasible.
  • The study identified predictors for AFib detection, with a higher frequency observed than previously reported.
  • This approach supports timely AFib diagnosis and management in ESUS patients.
Abstract